BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29944447)

  • 1. A novel immunodeficient rat model supports human lung cancer xenografts.
    He D; Zhang J; Wu W; Yi N; He W; Lu P; Li B; Yang N; Wang D; Xue Z; Zhang P; Fan G; Zhu X
    FASEB J; 2019 Jan; 33(1):140-150. PubMed ID: 29944447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies.
    Noto FK; Sangodkar J; Adedeji BT; Moody S; McClain CB; Tong M; Ostertag E; Crawford J; Gao X; Hurst L; O'Connor CM; Hanson EN; Izadmehr S; Tohmé R; Narla J; LeSueur K; Bhattacharya K; Rupani A; Tayeh MK; Innis JW; Galsky MD; Evers BM; DiFeo A; Narla G; Jamling TY
    PLoS One; 2020; 15(10):e0240169. PubMed ID: 33027304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a patient-derived xenograft model and cell line of malignant transformation of mature cystic teratoma of the ovary.
    Tamauchi S; Suzuki S; Xuboya C; Yoshihara M; Yoshida K; Ikeda Y; Yoshikawa N; Kajiyama H; Kikkawa F
    J Obstet Gynaecol Res; 2021 Feb; 47(2):713-719. PubMed ID: 33300248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
    Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
    Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological Characteristics of Severe Combined Immunodeficient Mice Produced by CRISPR/Cas9-Mediated
    Zhao Y; Liu P; Xin Z; Shi C; Bai Y; Sun X; Zhao Y; Wang X; Liu L; Zhao X; Chen Z; Zhang H
    Front Genet; 2019; 10():401. PubMed ID: 31134127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
    Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
    Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy.
    Wang M; Yao LC; Cheng M; Cai D; Martinek J; Pan CX; Shi W; Ma AH; De Vere White RW; Airhart S; Liu ET; Banchereau J; Brehm MA; Greiner DL; Shultz LD; Palucka K; Keck JG
    FASEB J; 2018 Mar; 32(3):1537-1549. PubMed ID: 29146734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOD-scidIl2rg (tm1Wjl) and NOD-Rag1 (null) Il2rg (tm1Wjl) : a model for stromal cell-tumor cell interaction for human colon cancer.
    Maykel J; Liu JH; Li H; Shultz LD; Greiner DL; Houghton J
    Dig Dis Sci; 2014 Jun; 59(6):1169-79. PubMed ID: 24798995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancer.
    John T; Kohler D; Pintilie M; Yanagawa N; Pham NA; Li M; Panchal D; Hui F; Meng F; Shepherd FA; Tsao MS
    Clin Cancer Res; 2011 Jan; 17(1):134-41. PubMed ID: 21081655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreak of Opportunistic Ascending Pyelonephritis with Numerous Yeast after Experimental Humanization Surgery in NOD.Cg-
    Zadrozny LM; Brinster LR; Rosenzweig BA; Howard KE
    Comp Med; 2018 Oct; 68(5):353-359. PubMed ID: 30208988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model.
    Oda Y; Niimi K; Yoshida K; Tamauchi S; Yokoi A; Yasui Y; Nishiko Y; Shibata M; Shimizu Y; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Yamamoto E; Kajiyama H
    BMC Cancer; 2023 Nov; 23(1):1103. PubMed ID: 37957624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneity.
    Chen X; Shen C; Wei Z; Zhang R; Wang Y; Jiang L; Chen K; Qiu S; Zhang Y; Zhang T; Chen B; Xu Y; Feng Q; Huang J; Zhong Z; Li H; Che G; Xiao K
    Cancer Biol Med; 2021 Feb; 18(1):184-198. PubMed ID: 33628593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthotopic Patient-Derived Pancreatic Cancer Xenografts Engraft Into the Pancreatic Parenchyma, Metastasize, and Induce Muscle Wasting to Recapitulate the Human Disease.
    Go KL; Delitto D; Judge SM; Gerber MH; George TJ; Behrns KE; Hughes SJ; Judge AR; Trevino JG
    Pancreas; 2017 Jul; 46(6):813-819. PubMed ID: 28609371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sprague Dawley
    Noto FK; Adjan-Steffey V; Tong M; Ravichandran K; Zhang W; Arey A; McClain CB; Ostertag E; Mazhar S; Sangodkar J; DiFeo A; Crawford J; Narla G; Jamling TY
    Mol Cancer Ther; 2018 Nov; 17(11):2481-2489. PubMed ID: 30206106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degenerative Myelopathy and Neuropathy in NOD.
    Yang P; Freeman ZT; Dysko RC; Hoenerhoff MJ
    Toxicol Pathol; 2022 Apr; 50(3):390-396. PubMed ID: 35450478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.
    Karalis JD; Yoon LY; Hammer STG; Hong C; Zhu M; Nassour I; Ju MR; Xiao S; Castro-Dubon EC; Agrawal D; Suarez J; Reznik SI; Mansour JC; Polanco PM; Yopp AC; Zeh HJ; Hwang TH; Zhu H; Porembka MR; Wang SC
    J Transl Med; 2022 Mar; 20(1):116. PubMed ID: 35255940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation.
    Dieter SM; Giessler KM; Kriegsmann M; Dubash TD; Möhrmann L; Schulz ER; Siegl C; Weber S; Strakerjahn H; Oberlack A; Heger U; Gao J; Hartinger EM; Oppel F; Hoffmann CM; Ha N; Brors B; Lasitschka F; Ulrich A; Strobel O; Schmidt M; von Kalle C; Schneider M; Weichert W; Ehrenberg KR; Glimm H; Ball CR
    Int J Cancer; 2017 Mar; 140(6):1356-1363. PubMed ID: 27935045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonobese diabetic/severe combined immunodeficient murine xenograft model for human uterine leiomyoma.
    Wang G; Ishikawa H; Sone K; Kobayashi T; Kim JJ; Kurita T; Shozu M
    Fertil Steril; 2014 May; 101(5):1485-92. PubMed ID: 24636398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps.
    Ilie M; Nunes M; Blot L; Hofman V; Long-Mira E; Butori C; Selva E; Merino-Trigo A; Vénissac N; Mouroux J; Vrignaud P; Hofman P
    Cancer Med; 2015 Feb; 4(2):201-11. PubMed ID: 25470237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review.
    Tanaka T; Nishie R; Ueda S; Miyamoto S; Hashida S; Konishi H; Terada S; Kogata Y; Sasaki H; Tsunetoh S; Taniguchi K; Komura K; Ohmichi M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.